1985
DOI: 10.1089/jir.1985.5.571
|View full text |Cite
|
Sign up to set email alerts
|

In VivoAugmentation of Natural Killer Activity by Combined Treatment with Recombinant Gamma Interferon and Interleukin-2

Abstract: The in vivo regulation of natural killer (NK) cell function by recombinant murine gamma interferon (rMuIFN-gamma) and recombinant human interleukin-2 (rHuIL-2) was investigated. Peritoneal exudate-derived natural killer (PE-NK) cells of mice treated with rMuIFN-gamma or rHuIL-2 exhibited significantly enhanced cytolytic activities against YAC-1 target cells. Compared with animals receiving treatment with either rMuIFN-gamma or rHuIL-2 alone, the sequential treatment of mice with both agents resulted in a signi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

1986
1986
2004
2004

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(10 citation statements)
references
References 27 publications
0
10
0
Order By: Relevance
“…The collaboration between IL-2 and IFN on NK activity in vivo has been reported. Shalaby et al demonstrated that, compared with animals receiving treatment with either IFN-y or IL-2 alone, the sequential treatment of mice with both agents resulted in a significantly greater enhancement of NK cell activity [35]. Thus the involvement of IFN-7 in the enhancement of NK activity is controversial.…”
Section: Discussionmentioning
confidence: 99%
“…The collaboration between IL-2 and IFN on NK activity in vivo has been reported. Shalaby et al demonstrated that, compared with animals receiving treatment with either IFN-y or IL-2 alone, the sequential treatment of mice with both agents resulted in a significantly greater enhancement of NK cell activity [35]. Thus the involvement of IFN-7 in the enhancement of NK activity is controversial.…”
Section: Discussionmentioning
confidence: 99%
“…To rule out that a significant increase in NK activity was not missed due to the early kinetics of the response, we examined YAC-1 killing in BALB/c mice receiving KBALB-GRP94⌬KDEL cells 0, 2, and 4 days following cell administration, and again we observed no significant increase (data not shown). As an internal control in these experiments, 51 Cr-labeled YAC-1 targets were incubated with splenocytes from naive BALB/c mice stimulated in vitro with 1000 U/ml rIL-2, a potent stimulus for NK activity (28). Under these conditions, a pronounced activation of YAC-1-directed NK function was observed ( Fig.…”
Section: In Vivo Administration Of Grp94/gp96-secreting Fibroblasts Dmentioning
confidence: 99%
“…TNF, like IFN, increases the expression of HLA-A, B antigens (38) suggesting that TNF may enhance the participation of cytolytic T lymphocytes in the destruction of neoplastic or virally-altered cells. In addition, TNF in vitro stimulates an increase in the phagocytic abilities of polymorphonuclear cells (10), cells which are capable of virus particle inactivation and tumor cell destruction (39,40). Recently, TNF was shown to protect 'aged" human fibroblasts from the cytopathic effect of encephalomyocarditis virus (41 …”
Section: D-i-s-czs ¶Io1mentioning
confidence: 99%
“…In addition to the historically studied cytotoxicity toward neoplastic tissue, a broad spectrum of activity has now been attributed to this molecule. TNF can participate in the inflammatory response by altering host metabolism and thereby mediating cachexia (9), activating polymorphonuclear neutrophil phagocytic and cytotoxic functions (10), enhancing eosinophil toxicity (11), and modulating the procoagulant properties of Nucleic Acids Research vascular endothelial cells (12,13). TNF can also stimulate bone resorption (14) and fibroblast growth (15).…”
Section: Introductiqmentioning
confidence: 99%